Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,901 | 223 | 94.2% |
| Education | $297.00 | 6 | 5.7% |
| Travel and Lodging | $2.92 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,041 | 35 | $0 (2024) |
| Novo Nordisk Inc | $706.93 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $436.59 | 21 | $0 (2024) |
| Lilly USA, LLC | $421.76 | 17 | $0 (2024) |
| Astellas Pharma US Inc | $395.92 | 12 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $227.53 | 6 | $0 (2023) |
| PFIZER INC. | $221.40 | 13 | $0 (2021) |
| Recor Medical Inc | $157.13 | 4 | $0 (2024) |
| ABBVIE INC. | $156.56 | 8 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $144.68 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $689.10 | 27 | AstraZeneca Pharmaceuticals LP ($157.44) |
| 2023 | $838.70 | 23 | AstraZeneca Pharmaceuticals LP ($283.49) |
| 2022 | $521.46 | 23 | Lilly USA, LLC ($206.65) |
| 2021 | $662.68 | 31 | Astellas Pharma US Inc ($111.69) |
| 2020 | $543.00 | 28 | AstraZeneca Pharmaceuticals LP ($90.78) |
| 2019 | $796.45 | 30 | Novo Nordisk Inc ($226.80) |
| 2018 | $517.42 | 32 | AstraZeneca Pharmaceuticals LP ($183.50) |
| 2017 | $632.32 | 36 | Novo Nordisk Inc ($202.91) |
All Payment Transactions
230 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Diabetes Care | ||||||
| 10/31/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/23/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $132.81 | General |
| Category: Endovascular | ||||||
| 09/23/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $4.65 | General |
| Category: Endovascular | ||||||
| 09/23/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $4.05 | General |
| Category: Endovascular | ||||||
| 09/04/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $15.62 | General |
| Category: Endovascular | ||||||
| 09/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Endocrinology | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: PSYCHIATRY | ||||||
| 07/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.68 | General |
| Category: PSYCHIATRY | ||||||
| 07/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Diabetes Care | ||||||
| 06/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Biological | ||||||
| 04/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Oncology | ||||||
| 04/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $117.83 | General |
| Category: Respiratory | ||||||
| 03/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: DIABETES | ||||||
| 03/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 574 | 839 | $83,057 | $57,789 |
| 2022 | 12 | 760 | 976 | $77,321 | $54,799 |
| 2021 | 17 | 1,136 | 1,517 | $126,614 | $92,966 |
| 2020 | 25 | 1,654 | 2,448 | $161,425 | $119,899 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 274 | $36,179 | $20,397 | 56.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 102 | 102 | $13,515 | $12,424 | 91.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 128 | $13,122 | $10,287 | 78.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 28 | $5,607 | $3,625 | 64.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 24 | 35 | $3,680 | $2,885 | 78.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 15 | $3,122 | $2,292 | 73.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 103 | 103 | $1,953 | $1,796 | 92.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 103 | 103 | $1,918 | $1,796 | 93.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $2,367 | $1,101 | 46.5% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 19 | 19 | $760.00 | $636.31 | 83.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $836.00 | $549.67 | 65.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 305 | $38,526 | $22,574 | 58.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 135 | 135 | $17,036 | $16,816 | 98.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 47 | $4,601 | $3,597 | 78.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 132 | 132 | $2,384 | $2,353 | 98.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 132 | 132 | $2,341 | $2,311 | 98.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 12 | $2,273 | $1,778 | 78.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 44 | $3,924 | $1,534 | 39.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $2,080 | $1,417 | 68.1% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 25 | 25 | $1,000 | $790.75 | 79.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $1,100 | $698.75 | 63.5% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 28 | 28 | $701.40 | $693.65 | 98.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 65 | 79 | $1,353 | $235.38 | 17.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 154 | 344 | $40,444 | $24,568 | 60.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 168 | 168 | $19,969 | $19,969 | 100.0% |
About Dr. Rodrigo Mata, M.D
Dr. Rodrigo Mata, M.D is a Internal Medicine healthcare provider based in Kenosha, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033148176.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rodrigo Mata, M.D has received a total of $5,201 in payments from pharmaceutical and medical device companies, with $689.10 received in 2024. These payments were reported across 230 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,901).
As a Medicare-enrolled provider, Mata has provided services to 4,124 Medicare beneficiaries, totaling 5,780 services with total Medicare billing of $325,453. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Kenosha, WI
- Active Since 07/01/2006
- Last Updated 06/03/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1033148176
Products in Payments
- FARXIGA (Drug) $749.17
- JARDIANCE (Drug) $343.90
- Saxenda (Drug) $257.48
- BREZTRI (Drug) $253.93
- MOUNJARO (Drug) $189.10
- ELIQUIS (Drug) $173.93
- PARADISE RENAL DENERVATION SYSTEM (Device) $157.13
- ZENPEP (Drug) $144.80
- TRULICITY (Drug) $131.60
- VOWST (Biological) $125.00
- JANUVIA (Drug) $113.27
- APTIOM (Drug) $106.25
- TRADJENTA (Drug) $101.79
- UBRELVY (Drug) $98.30
- ENTRESTO (Drug) $93.45
- XIFAXAN (Drug) $91.05
- FREESTYLE LIBRE 3 (Device) $78.81
- Tirosint (Drug) $73.43
- Ozempic (Drug) $69.43
- Xultophy 100/3.6 (Drug) $66.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kenosha
Dr. Hasnain Bawaadam, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $473,003
Alfred Habel, Md, MD
Internal Medicine — Payments: $223,905
Rosanna Ranieri, Md, MD
Internal Medicine — Payments: $64,322
Mario Garretto, Md, MD
Internal Medicine — Payments: $8,717
Dr. Sudip Ringwala, D.o, D.O
Internal Medicine — Payments: $6,114
Stefanie Ruffolo, M.d, M.D
Internal Medicine — Payments: $4,858